Bank of Montreal
FTH

Bank of Montreal’s Faeth Therapeutics FTH Stock Holding History

Bank of Montreal’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,395
Closed -$136K – 4270
2023
Q1 		$136K Buy
+4,395
New +$130K ﹤0.01% 3153
2021
Q2 		– Sell
-14
Closed -$4K – 4785
2021
Q1 		$4K Buy
+14
New +$4.68K ﹤0.01% 4758

Other funds holding FTH

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's FTH Position: Q2 2023 in Review

Bank of Montreal sold out of Faeth Therapeutics (FTH) in Q2 2023, closing a stake of 4,395 shares — an estimated $136K sold.

Bank of Montreal first reported a position in FTH in Q1 2021 and held it in 2 quarters. The position peaked at $136K in Q1 2023. 24 funds tracked by Wall St. Rank hold FTH as of Q2 2023.

  • Bank of Montreal reported no remaining Faeth Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 4,395 Faeth Therapeutics shares in Q2 2023, an estimated $136K.
  • Bank of Montreal first reported a position in Faeth Therapeutics in Q1 2021 and held it in 2 quarters.
  • Bank of Montreal's Faeth Therapeutics position peaked at $136K in Q1 2023.
  • 24 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.